McKesson Corporation
MCK
Classifica tra le azioni
#187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Prezzo delle azioni
$1,029.14
Capitalizzazione di mercato
$119.99B
Variazione (1 giorno)
1.73%
Variazione (1 anno)
30.63%
Paese
US
Scambia McKesson Corporation (MCK)
Categoria
Healthcare
Ricavi di McKesson Corporation (MCK)
Ricavi nel Jun 2026 TTM: $410.98B
Secondo gli ultimi rapporti finanziari di McKesson Corporation, i ricavi attuali dell'azienda (TTM) sono pari a $410.98B. Nel 2024, l'azienda ha registrato ricavi di $308.95B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $276.71B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per McKesson Corporation da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $410.98B | 14.46% |
| 2025 | $359.05B | 16.22% |
| 2024 | $308.95B | 11.65% |
| 2023 | $276.71B | 4.83% |
| 2022 | $263.97B | 10.80% |
| 2021 | $238.23B | 3.11% |
| 2020 | $231.05B | 7.81% |
| 2019 | $214.32B | 2.86% |
| 2018 | $208.36B | 4.95% |
| 2017 | $198.53B | 4.01% |
| 2016 | $190.88B | 6.61% |
| 2015 | $179.05B | 30.11% |
| 2014 | $137.61B | 12.38% |
| 2013 | $122.46B | -0.23% |
| 2012 | $122.73B | 9.50% |
| 2011 | $112.08B | 3.11% |
| 2010 | $108.70B | 1.94% |
| 2009 | $106.63B | 4.85% |
| 2008 | $101.70B | 9.39% |
| 2007 | $92.98B | 5.60% |
| 2006 | $88.05B | 9.36% |
| 2005 | $80.51B | 15.84% |
| 2004 | $69.51B | 21.68% |
| 2003 | $57.12B | 14.23% |
| 2002 | $50.01B | 19.03% |
| 2001 | $42.01B | 14.36% |
| 2000 | $36.73B | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| - | - |
US
|
|
| $254.25B | -38.14% |
US
|
|
| - | - |
US
|
|
| $7.64B | -98.14% |
AU
|
|
| $13.60B | -96.69% |
US
|
